Vanguard Portfolio Management’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
FLAM
CF
PVM
NI
Vanguard Portfolio Management's HCAT Position: Q2 2026 in Review
Vanguard Portfolio Management reduced its Health Catalyst (HCAT) stake by 77% in Q2 2026, selling an estimated $591K and leaving 121,412 shares worth $242K. The position accounts for ﹤0.01% of the portfolio, ranked #3108.
Vanguard Portfolio Management first reported a position in HCAT in Q1 2026 and has held it in 2 quarters since. The position peaked at $674K in Q1 2026. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.
- Vanguard Portfolio Management held 121,412 shares of Health Catalyst worth $242K as of Q2 2026.
- Vanguard Portfolio Management sold 409,602 Health Catalyst shares in Q2 2026, an estimated $591K.
- Health Catalyst made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #3108 holding.
- Vanguard Portfolio Management first reported a position in Health Catalyst in Q1 2026 and has held it in 2 quarters since.
- Vanguard Portfolio Management's Health Catalyst position peaked at $674K in Q1 2026.
- 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.
Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.